NAPROXEN AND ESOMEPRAZOLE MAGNESIUM

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 12, 2024
Approval ID: baf0a8a7-81dc-4b56-b097-c52ca286f41e
Products: 2 registered
Version: 11

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for NAPROXEN AND ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE TABLETS.NAPROXEN and ESOMEPRAZOLE MAGNESIUM delayed-release tablets, for oral useInitial U.S. Approval: 2010

Quick Stats

Total Products2

Labelers2

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.